Who is the CEO of Onyx Biotec Ltd?
- Answer Field
-
Sanjay Jain is the CEO, leading strategic and operational growth initiatives
BAJAJ BROKING
Overview of the Company
Onyx Biotec Limited, incorporated in May 2005, specializes in manufacturing sterile water for injections and operates as a pharmaceutical contract manufacturer. With a broad range of dry powder injections and syrups, the company caters to both Indian and international clients. Onyx Biotec’s two manufacturing units, located in Solan, Himachal Pradesh, offer robust production capabilities, delivering high-quality pharmaceutical solutions.
Core Business and Market Position
The company’s core business revolves around supplying sterile injections and providing contract manufacturing services for leading pharmaceutical brands such as Hetero Healthcare and Sun Pharmaceuticals. Boasting certifications like ISO 9001:2015 and ISO 14001:2015, Onyx Biotec has solidified its position as a reputable name in the pharmaceutical sector. Its impressive client list of over 100 firms highlights its market reach and reliability.
The Onyx Biotec IPO will be a fresh issue of 4.81 million shares aggregating to ₹29.34 crores.
IPO Details Table:
Detail | Information |
IPO Open Date | November 13, 2024 |
IPO Close Date | November 18, 2024 |
Listing Exchange | NSE SME |
Price Band | ₹58 to ₹61 per share |
Lot Size | 2000 Shares |
Issue Size | 4,810,000 shares (₹29.34 Cr) |
Purpose of the IPO:
Event | Date |
IPO Open Date | November 13, 2024 |
IPO Close Date | November 18, 2024 |
Basis of Allotment | November 19, 2024 |
Initiation of Refunds | November 20, 2024 |
Credit to Demat | November 20, 2024 |
Listing Date | November 21, 2024 |
Online Application Process:
Key Financial Metrics:
Recent Performance and Growth Prospects:
Potential Risks of Investing in the IPO:
Opportunities and Growth Potential:
KPI | Values |
ROE | 4.99% |
ROCE | 3.71% |
Debt/Equity | 1.21 |
P/BV | 3.1 |
PAT Margin (%) | 12.42% |
Role | Name | Contact Details |
Registrar | Mas Services Limited | Phone: (011) 2610 4142 |
Lead Manager(s) | Horizon Management Private Limited | - |
Onyx Biotec Limited
Bir Plassi, Near Sainimajraropar,
Nalagarh Road, District Solan – 174101,
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: onyxbiotec.com
The Onyx Biotec IPO presents an opportunity for investors to be part of a growing pharmaceutical player known for its quality and established market reach. While the IPO carries risks typical of the industry, the growth potential and strong client network offer promising returns for informed investors.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Morgan Stanley Acquires 1.4 Crore PNB Housing Finance Shares for ₹1,336 Crore
14 Nov, 2024 | 2 Min. read
Varun Beverages Opens ₹5,500 Crore QIP, Sets Floor Price at ₹594.56
14 Nov, 2024 | 2 Min. read
Tata Power Commissions 126 MW Floating Solar Project in Madhya Pradesh
14 Nov, 2024 | 2 Min. read
Cipla Receives US FDA Form 483 with Eight Observations at Bengaluru Unit
14 Nov, 2024 | 2 Min. read
Devyani International Q2 Results FY24-25 Preview | Estimate
13 Nov, 2024 | 1 Min. read
Bank of India Q2 Results FY24-25 Preview | Estimate
13 Nov, 2024 | 1 Min. read
Tata Chemicals Europe to Invest ₹655 Crore in UK Sodium Bicarbonate Plant
13 Nov, 2024 | 2 Min. read
EMS Secures ₹681.5 Crore JV Contract with Kolkata Municipal Corporation
13 Nov, 2024 | 2 Min. read
Federal Bank Raises ₹1,500 Crore in Maiden Infrastructure Bond Issuance
13 Nov, 2024 | 2 Min. read
Quality Investment Holdings PCC to Sell 9.43% Stake in PNB Housing Finance
13 Nov, 2024 | 2 Min. read
Share Market Today | Nifty Hints At Negative Opening Amid Global Profit Booking
13 Nov, 2024 | 4 Min. read
BSE Q2 Results FY24-25 Preview | Estimate
13 Nov, 2024 | 1 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Sanjay Jain is the CEO, leading strategic and operational growth initiatives
The IPO opens on November 13, 2024, and closes on November 18, 2024.
The price band is ₹58 to ₹61 per share, based on demand and market valuation.
You can apply by logging into your Bajaj Broking Demat account, selecting the IPO, entering lot details, and completing ASBA or UPI mandate.
Key risks include market competition and regulatory challenges. Rewards stem from growth potential and a strong client network.
Review the RHP, financial statements, and company history for informed decision-making.
Specific lock-up details are not available.
Dividend distribution depends on future profitability and board decisions.
No Result Found
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading